For the Inventor, By the Inventor

Enter assignee name

Piramal Enterprises Limited

USPTO Granted Patents = 48

CIPO Patents = 7

EPO Patents = 20

Trademarks = 8

Forward Citations = 106

Loading Chart...

Loading Chart...

116 inventors (with patents filed for the assignee):

Rajiv Sharma (13 out of 28 patents)

Veena R Agarwal (10 out of 10 patents)

Sanjay Kumar (9 out of 24 patents)

4. Sreesha Srinivasa (7 out of 8 patents)

5. Maggie Rathos (7 out of 7 patents)

6. Kalpana Sanjay Joshi (6 out of 38 patents)

7. Milind Moreshwar Gharpure (6 out of 12 patents)

8. Giridharan Periyasamy (5 out of 5 patents)

9. Somesh Sharma (5 out of 11 patents)

10. Owe Orwar (4 out of 26 patents)

11. Prabha Mishra (4 out of 4 patents)

12. Swati Ajay Piramal (4 out of 7 patents)

13. Muralidhara Padigaru (4 out of 4 patents)

14. Gandhali Ashwin Deshpande (4 out of 4 patents)

15. Vijaykumar Bhagwan Deore (4 out of 4 patents)

Core Competencies:

Pharmaceutical Combinations

Cancer Treatment

GPR120 Agonists

SGLT2 Inhibitors

ROR-Gamma Modulators

Hexadepsipeptide Analogues

Imidazoquinoline Derivatives

Diacylglycerol Acyltransferase Inhibitors

Fused Heterocyclic Compounds

Tricyclic Compounds

Oral Pharmaceutical Composition

Macrocyclic Lactone Derivatives

48 patents: Sort by Forward Citations

1. 12383530 - Pharmaceutical combination for the treatment of melanoma (2025-08-12),

2. 12383529 - Pharmaceutical combination for the treatment of cancer (2025-08-12),

3. 12076309 - Compounds for the treatment of cancers associated with human papillomavirus (2024-09-03),

4. 11925618 - Pharmaceutical combination for the treatment of cancer (2024-03-12),

5. 11839591 - Pharmaceutical combination for the treatment of melanoma (2023-12-12),

6. 11773077 - Compounds containing carbon-carbon linker as GPR120 agonists (2023-10-03),

7. 11260055 - Oral pharmaceutical composition of lurasidone and preparation thereof (2022-03-01),

8. 11234963 - Pharmaceutical combination for the treatment of cancer (2022-02-01),

9. 11198703 - Process for the preparation of SGLT2 inhibitors and intermediates thereof (2021-12-14),

10. 11160789 - Compounds for the treatment of cancers associated with human papillomavirus (2021-11-02),

11. 11084784 - ROR-gamma modulators and uses thereof (2021-08-10),

12. 11007174 - Pharmaceutical combination for the treatment of melanoma (2021-05-18),

13. 10980776 - Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck (2021-04-20),

14. 10941133 - Compounds containing carbon-carbon linker as GPR120 agonists (2021-03-09),

15. 10688079 - Compounds for the treatment of cancers associated with human papillomavirus (2020-06-23),

Piramal Enterprises Limited is a global business conglomerate with operations in multiple sectors, including pharmaceuticals, financial services, and real estate. With a presence in over 30 countries, the company is committed to creating long-term value for its stakeholders. Piramal Enterprises operates through various subsidiaries and offers a wide range of products and services to cater to diverse customer needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

48 Patents

#7 in Mumbai

#37 in India

#14,122 in the World

Piramal Enterprises Limited

Forward Citations = 106

116 inventors:

Rajiv Sharma (13 out of 28 patents)

Veena R Agarwal (10 out of 10 patents)

Sanjay Kumar (9 out of 24 patents)

4. Sreesha Srinivasa (7 out of 8 patents)

5. Maggie Rathos (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…